Intelligent Bio Solutions Income Statement (2019-2024) | INBS

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024
Revenue & cost
Revenue (Quarter) 798.000.00M0.07M0.06M0.28M0.03M0.42M0.18M0.19M1.19M0.35M0.36M0.46M0.44M0.80M0.76M0.82M
Cost of Revenue (Quarter) 0.11M0.42M0.39M0.56M0.56M0.65M
Gross Profit (Quarter) 0.24M0.03M0.05M0.23M0.20M0.18M
Operating items
Depreciation & Amortization - Total (Quarter) 0.01M0.02M
Research & Development (Quarter) 0.49M-0.06M0.05M0.03M0.34M0.50M1.31M0.11M2.64M0.41M0.69M0.08M0.00M0.30M0.13M0.10M0.35M0.47M
Selling, General & Administrative (Quarter) 0.97M0.05M0.45M0.52M0.67M1.01M1.15M1.33M1.00M1.12M1.46M1.45M2.25M1.90M2.43M2.46M1.71M2.43M
Restructuring Costs (Quarter) 0.03M
Other Operating Expenses (Quarter) 0.24M0.03M0.08M0.17M0.19M1.66M524.00-1.34M-2.08M-1.21M-0.42M-6.34M-2.66M0.31M0.29M0.32M
Operating Expenses (Quarter) 1.70M0.03M0.58M0.72M1.20M3.17M2.46M1.44M3.64M1.54M2.15M1.53M2.64M6.69M2.79M2.87M2.34M3.22M
Operating Income (Quarter) -1.70M-0.03M-0.51M-0.66M-0.92M-3.14M-0.85M-1.44M-3.47M-1.34M-2.09M-1.22M-2.13M-6.54M-2.70M-2.53M-1.99M-2.95M
EBIT (Quarter) -1.70M-0.03M-0.51M-0.66M-0.92M-3.14M-0.85M-1.44M-3.47M-1.34M-2.09M-1.22M-2.13M-6.54M-2.70M-2.53M-1.99M-2.95M
Non-operating items
Non Operating Investment Income (Quarter) -0.14M
Interest & Investment Income (Quarter) 27.0022.006.0070.00434.000.01M0.01M0.00M0.00M0.00M0.00M0.01M0.00M508.0089.00139.000.00M0.01M
Other Non Operating Income (Quarter) -0.19M-0.09M0.01M-892.00-0.00M14.0010.00-893.00-0.00M-0.01M0.01M-893.00-555.00-996.00
Non Operating Income (Quarter) -0.15M-0.08M0.04M-0.41M-1.07M-0.00M0.00M0.00M0.00M-0.00M-87.000.00M1.70M0.19M0.03M0.09M0.01M-0.03M
Net income details
EBT (Quarter) -1.85M-0.11M-0.46M-1.08M-1.99M-3.14M-0.85M-1.44M-3.46M-1.34M-2.08M-1.21M-2.13M-6.35M-2.70M-2.56M-2.02M-2.99M
Profit After Tax (Quarter) -1.85M-0.11M-1.84M-1.08M-1.99M-3.13M-0.85M-1.44M-3.46M-1.34M-2.06M-1.21M-0.43M-6.34M-2.66M-2.43M-1.98M-2.98M
Equity Income (Quarter) 1.79M0.27M0.09M0.13M0.04M
Income from Non-Controlling Interests (Quarter) -0.02M0.00M-0.01M-0.00M-0.01M-0.01M0.00M-0.01M-0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M
Income from Continuing Operations (Quarter) -1.85M-0.11M-0.46M-1.08M-1.99M-3.14M-0.85M-1.44M-3.46M-1.34M-2.08M-1.21M-2.13M-6.35M-2.70M-2.56M-2.02M-2.99M
Consolidated Net Income (Quarter) -1.85M-0.11M-0.46M-1.08M-1.99M-3.14M-0.85M-1.44M-3.46M-1.34M-2.08M-1.21M-2.13M-6.35M-2.70M-2.56M-2.02M-2.99M
Income towards Parent Company (Quarter) -1.85M-0.11M-0.46M-1.08M-1.99M-3.14M-0.85M-1.44M-3.46M-1.34M-2.08M-1.21M-2.13M-6.35M-2.70M-2.56M-2.02M-2.99M
Net Income towards Common Stockholders (Quarter) -1.85M-0.11M-0.46M-1.08M-1.99M-3.14M-0.85M-1.44M-3.46M-1.34M-2.08M-1.21M-2.13M-6.35M-2.70M-2.56M-2.02M-2.99M
Additional items
EPS (Basic) (Quarter) -0.22-0.01-0.05-0.12-0.23-0.27-0.04-0.10-4.65-1.79-2.79-1.62-5.56-68.67-22.96-12.48-2.07-1.43
EPS (Weighted Average and Diluted) (Quarter) -2.84-1.63-5.56-68.67-22.96-12.48-2.07-1.43
Shares Outstanding (Weighted Average) (Quarter) 8.51M8.51M8.51M8.63M8.62M9.67M10.41M14.01M0.74M0.74M0.73M14.89M0.08M0.09M0.08M0.19M0.95M2.08M
Shares Outstanding (Diluted Average) (Quarter) 0.73M0.74M0.08M0.08M0.08M0.19M0.57M2.08M
EBITDA (Quarter) -1.70M-0.03M-0.51M-1.13M-1.96M-3.39M-0.87M-1.50M-3.46M-1.34M-2.16M-1.34M-0.07M-6.43M-2.59M-2.44M-1.90M-3.12M
Interest Expenses (Quarter) 0.04M0.03M0.04M